67 related articles for article (PubMed ID: 19647218)
1. The SPS affair: a complex tale of illicit proliferation.
Braun BS; Shannon K
Cancer Cell; 2009 Aug; 16(2):87-8. PubMed ID: 19647218
[TBL] [Abstract][Full Text] [Related]
2. Tumor suppression by phospholipase C-beta3 via SHP-1-mediated dephosphorylation of Stat5.
Xiao W; Hong H; Kawakami Y; Kato Y; Wu D; Yasudo H; Kimura A; Kubagawa H; Bertoli LF; Davis RS; Chau LA; Madrenas J; Hsia CC; Xenocostas A; Kipps TJ; Hennighausen L; Iwama A; Nakauchi H; Kawakami T
Cancer Cell; 2009 Aug; 16(2):161-71. PubMed ID: 19647226
[TBL] [Abstract][Full Text] [Related]
3. Short Stat5-interacting peptide derived from phospholipase C-β3 inhibits hematopoietic cell proliferation and myeloid differentiation.
Yasudo H; Ando T; Xiao W; Kawakami Y; Kawakami T
PLoS One; 2011; 6(9):e24995. PubMed ID: 21949826
[TBL] [Abstract][Full Text] [Related]
4. Lyn- and PLC-beta3-dependent regulation of SHP-1 phosphorylation controls Stat5 activity and myelomonocytic leukemia-like disease.
Xiao W; Ando T; Wang HY; Kawakami Y; Kawakami T
Blood; 2010 Dec; 116(26):6003-13. PubMed ID: 20858858
[TBL] [Abstract][Full Text] [Related]
5. Repression of SHP-1 expression by p53 leads to trkA tyrosine phosphorylation and suppression of breast cancer cell proliferation.
Montano X
Oncogene; 2009 Oct; 28(43):3787-800. PubMed ID: 19749791
[TBL] [Abstract][Full Text] [Related]
6. Critical role for mast cell Stat5 activity in skin inflammation.
Ando T; Xiao W; Gao P; Namiranian S; Matsumoto K; Tomimori Y; Hong H; Yamashita H; Kimura M; Kashiwakura J; Hata TR; Izuhara K; Gurish MF; Roers A; Rafaels NM; Barnes KC; Jamora C; Kawakami Y; Kawakami T
Cell Rep; 2014 Jan; 6(2):366-76. PubMed ID: 24412367
[TBL] [Abstract][Full Text] [Related]
7. A role of Gab2 association in Flt3 ITD mediated Stat5 phosphorylation and cell survival.
Masson K; Liu T; Khan R; Sun J; Rönnstrand L
Br J Haematol; 2009 Jul; 146(2):193-202. PubMed ID: 19438505
[TBL] [Abstract][Full Text] [Related]
8. Regulation of proliferation, survival, differentiation, and activation by the Signaling Platform for SHP-1 phosphatase.
Kawakami T; Xiao W; Yasudo H; Kawakami Y
Adv Biol Regul; 2012 Jan; 52(1):7-15. PubMed ID: 21982978
[No Abstract] [Full Text] [Related]
9. Modulation of STAT5 interaction with LMW-PTP during early megakaryocyte differentiation.
Rigacci S; Guidotti V; Parri M; Berti A
Biochemistry; 2008 Feb; 47(6):1482-9. PubMed ID: 18197699
[TBL] [Abstract][Full Text] [Related]
10. Selective activation of the "b" splice variant of phospholipase Cbeta1 in chronically dilated human and mouse atria.
Woodcock EA; Grubb DR; Filtz TM; Marasco S; Luo J; McLeod-Dryden TJ; Kaye DM; Sadoshima J; Du XJ; Wong C; McMullen JR; Dart AM
J Mol Cell Cardiol; 2009 Nov; 47(5):676-83. PubMed ID: 19729020
[TBL] [Abstract][Full Text] [Related]
11. Nuclear inositides: PI-PLC signaling in cell growth, differentiation and pathology.
Cocco L; Faenza I; Follo MY; Billi AM; Ramazzotti G; Papa V; Martelli AM; Manzoli L
Adv Enzyme Regul; 2009; 49(1):2-10. PubMed ID: 19159640
[No Abstract] [Full Text] [Related]
12. Protein kinase B/Akt signals impair Th17 differentiation and support natural regulatory T cell function and induced regulatory T cell formation.
Pierau M; Engelmann S; Reinhold D; Lapp T; Schraven B; Bommhardt UH
J Immunol; 2009 Nov; 183(10):6124-34. PubMed ID: 19841181
[TBL] [Abstract][Full Text] [Related]
13. Regulation of retinal angiogenesis by phospholipase C-β3 signaling pathway.
Ha JM; Baek SH; Kim YH; Jin SY; Lee HS; Kim SJ; Shin HK; Lee DH; Song SH; Kim CD; Bae SS
Exp Mol Med; 2016 Jun; 48(6):e240. PubMed ID: 27311705
[TBL] [Abstract][Full Text] [Related]
14. Activation of the mouse TCRgamma enhancers by STAT5.
Tani-ichi S; Satake M; Ikuta K
Int Immunol; 2009 Sep; 21(9):1079-88. PubMed ID: 19651644
[TBL] [Abstract][Full Text] [Related]
15. Signal transducer and activator of transcription 5 tyrosine phosphorylation for the diagnosis and monitoring of patients with severe combined immunodeficiency.
Walshe D; Gaspar HB; Thrasher AJ; Cale CM; Gilmour KC
J Allergy Clin Immunol; 2009 Feb; 123(2):505-8. PubMed ID: 19203666
[No Abstract] [Full Text] [Related]
16. Single-cell profiling identifies aberrant STAT5 activation in myeloid malignancies with specific clinical and biologic correlates.
Kotecha N; Flores NJ; Irish JM; Simonds EF; Sakai DS; Archambeault S; Diaz-Flores E; Coram M; Shannon KM; Nolan GP; Loh ML
Cancer Cell; 2008 Oct; 14(4):335-43. PubMed ID: 18835035
[TBL] [Abstract][Full Text] [Related]
17. Immune regulation by phospholipase C-β isoforms.
Xiao W; Kawakami Y; Kawakami T
Immunol Res; 2013 May; 56(1):9-19. PubMed ID: 22638704
[TBL] [Abstract][Full Text] [Related]
18. Stat5 as a diagnostic marker for leukemia.
Lewis RS; Ward AC
Expert Rev Mol Diagn; 2008 Jan; 8(1):73-82. PubMed ID: 18088232
[TBL] [Abstract][Full Text] [Related]
19. Phospholipase C-β in immune cells.
Kawakami T; Xiao W
Adv Biol Regul; 2013 Sep; 53(3):249-57. PubMed ID: 23981313
[TBL] [Abstract][Full Text] [Related]
20. SHP-1 exhibits a pro-apoptotic function in antigen-stimulated mast cells: positive regulation of mitochondrial death pathways and negative regulation of survival signaling pathways.
Inoue T; Suzuki Y; Mizuno K; Nakata K; Yoshimaru T; Ra C
Mol Immunol; 2009 Dec; 47(2-3):222-32. PubMed ID: 19875169
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
